Our Services
We provide a comprehensive array of financial services to a diverse range of corporate clients, institutional investors, and high net worth investors.
Investment Banking
Equity Research
Capital Markets
Merchant Capital
Wealth Management
Prime Brokerage
Recent
Transactions
Over 140 financings and $6.8 Billion in aggregate as Lead, Joint, or Co-Manager in 2020
Reverse Merger
// Financial Advisor
March 2021
$50.0 Million
CMPO
// Co-Manager
March 2021
$6.0 Million
PIPE
// Lead Placement Agent
March 2021
$75.0 Million
Initial Public Offering
// Co-Manager
March 2021
$16.0 Million
Registered Direct Offering
// Sole Placement Agent
March 2021
$50.0 Million
Initial Public Offering
// Sole Book-Running Manager
March 2021
$45.0 Million
Follow-On Offering
// Financial Advisor
February 2021
$20.0 Million
Follow-On Offering
// Sole Book-Runner
February 2021
$96.7 Million
Warrant Solicitation
// Sole Placement Agent
February 2021
$440.0 Million
Follow-On Offering
// Co-Manager
February 2021
$11.7 Million
PIPE
// Sole Placement Agent
February 2021
![Maxim_Merchant-Capital_logo-01[1]](https://www.maximgrp.com/wp-content/uploads/2020/02/Maxim_Merchant-Capital_logo-011.svg "Maxim_Merchant-Capital_logo-01[1]"){kind=logo}
Merchant Capital
Maxim Merchant Capital’s skilled specialists have significant experience in raising private capital for both late-stage and early-stage private and public companies across a range of industries; predominantly in life sciences/biotechnology. Within the biotech sector, we look for companies that address significant unmet needs and have a clear regulatory path.